Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector CDMO specializing in advanced therapies, today announced a strategic partnership with Calidi Biotherapeutics, Inc. ("Calidi"), a ...

A deepfake video falsely portraying Irish presidential candidate Catherine Connolly as withdrawing from the race has rapidly ...

Researchers at Washington University School of Medicine in St. Louis have identified central routes that two deadly viruses take to invade human cells and have designed decoy molecules that block the ...

The signing took place at KFSHRC's pavilion during the Global Health Exhibition 2025, with signatories: Dr. Majid Alfayyadh, ...

SII will collaborate with CEPI and the University of Oxford to produce the ChAdOx1 NipahB vaccine for Phase II clinical ...

OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised as a Champion in the ‘Cell & Gene Therapy’ category at the 2025 CDMO Leadership ...

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...

Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality ...

Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...

Rated Red reveals how Game Vector technology helps hunters track prey. Police may have found a new serial killer Republicans are ridiculing ‘No Kings.’ A striking new poll shows Americans aren’t ...

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology ...